Event Brief
Feb 23, 2026 at 7:05 AM ET
Gilead to Acquire Arcellx for Up to $7.8bn
By The BriefBrief
Gilead Sciences plans to purchase Arcellx as part of a trend in biotech acquisitions.
WHO: Gilead Sciences
WHAT: Acquisition of Arcellx
WHEN: Feb 23, 2026 at 6:02 AM ET
WHERE: Location not specified
WHY: To enhance drug pipeline amid industry consolidation
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21419 of 21419
Same format. Every time.
Continue reading — sign in or create a free account with
